Why the study?
Type 2 diabetes mellitus-induced cardiomyopathy involves oxidative stress, and curcumin is an antioxidant natural polyphenol that plays a role in anti-apoptotic and anti-inflammatory effects in diabetes.
Does curcumin reduce myocardial apoptosis and lipid accumulation in a mouse model of diabetic cardiomyopathy?
Does curcumin reduce myocardial apoptosis and lipid accumulation in a mouse model of diabetic cardiomyopathy?
Curcumin demonstrates protective effects against diabetic cardiomyopathy in a mouse model by inhibiting ROS production and reducing myocardial apoptosis.
Curcumin may attenuate diabetic cardiomyopathy in mice; hypothesis-generating and requires human trials before any clinical consideration.
Type 2 diabetes mellitus (DM)-induced cardiomyopathy is a multifactorial and complex disease involving oxidative stress, lipids, and fibrosis. It is based on metabolic disorders and microvascular disease and causes extensive focal necrosis of the heart muscle. Curcumin (CUR) is a natural polyphenol isolated from turmeric rhizomes and plays an important role in the antioxidant, anti-apoptotic and anti-inflammatory effects of diabetes. Therefore, we established a mouse model of diabetic cardiomyopathy (DCM) in type 2 diabetic db/db mice in our study. We divided the experiment into three groups: the control group, DM group and DM + CUR group.We performed cardiac dissection on mice treated in different conditions and conducted special pathological staining on isolated cardiac tissue. We were surprised to find that a high glucose environment can promote cardiomyocyte apoptosis by TUNEL assay. In addition, after detecting dihydroethiidine (DHE), hematoxylin-eosin (H&E) and Oil Red O staining, we unexpectedly found that CUR can inhibit the production of reactive oxygen species (ROS), reduce myocardial apoptosis, and myocardial lipid accumulation. CUR upregulated the expression of Bcl-2, and downstream the expression of Bax and Caspase-3 proteins by immunohistochemical determination and western blotting. Therefore, these results suggest that CUR has a certain protective effect on diabetic cardiomyopathy by inhibiting the production of ROS.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: